In another study, Biberacher et al. showed that bryostatin 1 sensitizes chronic lymphocytic leukemia cells to the cytotoxic effects of BL22 via activation of protein kinase C and subsequent increased surface expression of CD22. Here, CD22 is linked to B-cell chronic lymphocytic leukemia.